WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'6001 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 11'6541 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 345  338  332  326  320  273  216  154 
Births
Surviving infants
Pop. less than 5 years 37  36  35  33  32  35  41  27 
Pop. less than 15 years 99  99  98  98  98  113  101  69 
Female 15-49 years 100  98  96  94  92  66  45  33 

Number of reported case

(Click for retrospective incidence data for Maldives)
Diphtheria
Japanese encephalitis
Measles 20 
Mumps 17  14  69  50  71 
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Maldives)
Vaccine year result method % card seen                                                
BCG 2008  99  DHS   89  100  100  98  97  99  99  99 
DTP1 2008  99  DHS   89  99  99  97  97  99  99 
DTP3 2008  98  DHS   89  99  100  96  96  98  98  94 
HepB_BD          100  99  98  97  99  62 
HepB3 2008  97  DHS   89  99  99  96  97  98  96 
Hib3          100 
JapEnc         
MCV 2008  95  DHS   89  99  98  96  97  98  99  96 
MCV2          99  99  96  96 
PCV1         
PCV3         
Pol3 2008  97  DHS   89  100  99  96  97  98  98  94 
Rota1         
Rota_last         
Rubella1          99  99  96  97  96 
TT2plus 2000  43  MICS     100  99  92  95  95  98  89 
PAB         
VAD1          96  91  93  98 
YFV          100 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Maldives)
BCG 99  99  98  97  99  99  99 
DTP1 99  99  97  97  99  98  97  22 
DTP3 99  99  96  96  98  98  94 
HepB3 99  99  96  97  98  96 
HepB_BD 99  99  98  97  99  62 
Hib3 58 
MCV 99  98  96  97  98  99  96 
MCV2 99  99  96  96  96 
PAB 95  95  95  95  95  95  86 
PCV3
Pol3 99  99  96  97  98  98  94 
Rota_last

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 105
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT Those who can't be given DTP
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth;
Influenza > 15 years; Yes Pilgrims
Measles 9 months;
MenACWY >= 15 years; Yes pilgrims
MMR 18 months;
OPV birth; 2, 4, 6 months;
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 9, 18, 24, 30, 36, 42 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  No    No  No 
What years does the MYP cover? number 2009-2013  2009-2013  2009-2013         
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20  20  20  20   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 21  20  20  20  20  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 105  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 21  20  20  20  18  20   
% of districts with MCV1 coverage >=95% From 0 to 100% 105  100  100  100  90  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.